Total trials
453
Active
100
Phase 3
6
Total enrollment
3,475,063
Pipeline matrix
Showing 22 of 22 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Anesthesia Maintenance Agent | — | — | — | — | — | 1 | |
| Pivmecillinam | — | — | — | — | — | 1 | |
| Standard of Care | — | — | — | — | — | 1 | |
| nivolumab or pembrolizumab | — | — | — | — | — | 1 | |
| 5Fluorouracil | — | — | — | — | — | 1 | |
| Irinotecan | — | — | — | — | — | 1 | |
| Oxaliplatin | — | — | — | — | — | 1 | |
| Spironolactone | — | — | — | — | — | 1 | |
| Rituximab | — | — | — | — | — | 1 | |
| CAR20(NAP)-T | — | — | — | — | — | 1 | |
| Cyclophosphamide | — | — | — | — | — | 1 | |
| Fludarabine | — | — | — | — | — | 1 | |
| Sequential treatment with rituximab and cladribine | — | — | — | — | — | 1 | |
| the ATMP Protrans | — | — | — | — | — | 1 | |
| Atezolizumab | — | — | — | — | — | 1 | |
| Everolimus | — | — | — | — | — | 1 | |
| Cobimetinib | — | — | — | — | — | 1 | |
| Niraparib | — | — | — | — | — | 1 | |
| AdVince | — | — | — | — | — | 1 | |
| ADT + NHT + Docetaxel | — | — | — | — | — | 1 | |
| ADT + NHT | — | — | — | — | — | 1 | |
| Bortezomib-bendamustine-melphalan | — | — | — | — | — | 1 |
Next readouts
- 2024-01-31
- 2025-03-31
- 2025-08
- 2025-12
- 2026-12
- 2026-12-10
- 2026-12-31
- 2027-12-30
- 2028-04-01
- 2028-09
Top conditions
- Obesity11
- Chronic Pain10
- Depression9
- Sepsis9
- Acute Kidney Injury8
- Breast Cancer8
- Quality of Life7
- Myocardial Infarction7
Frequently asked questions about Uppsala University
- How many clinical trials does Uppsala University have on ClinicalTrials.gov?
- Uppsala University is listed as the lead sponsor on 453 clinical trials in ClinicalTrials.gov, 100 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Uppsala University's trials are in Phase 3?
- 6 of Uppsala University's trials are in Phase 3, spread across 22 active drug programs.
- What therapeutic areas does Uppsala University focus on?
- Uppsala University's most-studied conditions on ClinicalTrials.gov are Obesity, Chronic Pain, Depression, Sepsis, Acute Kidney Injury.
- When are Uppsala University's next clinical trial readouts?
- Uppsala University has 10 upcoming primary-completion readouts tracked here; the soonest is “A MolEcularly Guided Anti-Cancer Drug Off-Label Trial”, expected around 2024-01-31.